RE:RE:RE:RE:Tic Toc goes the clock, DEAs1, good thing is Medipharm is not solely reliant on the US market, as they are also targetting and embedded in countries like Germany, Brazil, Austrailia, etc, where politics moves at differing paces and agendas.
Got to be in it to win it, and Labs has a pretty large global foot print in those exciting upstarts, so now we wait patiently for those who have the power to make it reality!
Q4 / Q1 fins should be a good indicator of current corporate activity and health.